Yahoo Web Search

    • Agios: A Look At TIBSOVO In CC Patients (NASDAQ:AGIO)

      Seeking Alpha· 3 days ago

      In April 2020, when Agios Pharmaceuticals, Inc. (AGIO) was trading near $30, we said it was a buy. The company is now planning to submit a Supplemental New Drug Application (sNDA) in 1Q-2021 ...

  1. Related searches

    acute myeloid leukemia